<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">Treatments for asthmatic patients are mainly based on inhaled corticosteroids and long-acting Î²2-adrenoceptor agonists, however, these drugs do not prevent viral-induced exacerbations. Several specific antiviral treatments, targeting infection, are currently under development for effective clinical management and reduced morbidity.</p>
